FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention relates to the pharmaceutical industry, namely to the composition for the treatment of diabetes with hypoglycemic effect. Composition for the treatment of diabetes has a high hypoglycemic effect that suppresses lactic acidosis without a significant increase in the concentration of lactate in the blood, containing active ingredients: branched chain amino acids and a biguanide derivative.
EFFECT: proposed composition suppresses the side effects of metformin, enhances the hypoglycemic effect.
14 cl, 12 tbl, 12 ex, 1 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| SOLID UNIT DOSAGE FORM FOR PANCREATIC DIABETES | 2009 |
|
RU2380097C1 |
| COMBINATION FOR TREATMENT OF DIABETES AND COMPLICATIONS THEREOF | 2011 |
|
RU2451506C1 |
| PANCREATIC DIABETES DRUG | 2004 |
|
RU2358738C2 |
| PHARMACEUTICAL COMBINATION CONTAINING SGLT2 INHIBITOR | 2008 |
|
RU2489151C2 |
| SOLID DOSED FORMULATION FOR TREATMENT OF PANCREATIC DIABETES | 2006 |
|
RU2333760C2 |
| PHARMACEUTICAL COMPOSITION POSSESSING ANTIDIABETIC, HYPOLIPIDEMIC, HYPOGLYCEMIC AND CHOLESTEROL LOWERING ACTION, WAY OF ITS RECEPTION AND WAYS OF TREATMENT OF SPECIFIED DISEASES | 2007 |
|
RU2361581C2 |
| METHOD OF IMPROVEMENT OF LIVER FUNCTION | 2013 |
|
RU2653478C2 |
| METHOD OF WEIGHT REDUCTION | 2013 |
|
RU2664442C2 |
| APPLICATION OF DPP-IV INHIBITOR FOR REDUCTION OF GLYCEMIA ACUTE EXACERBATION | 2006 |
|
RU2440143C2 |
| DERIVATIVES OF BIGUANIDE AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 2002 |
|
RU2276136C2 |
